11.76
+0.25(+2.17%)
Currency In USD
Address
419 Davis Drive
Morrisville, NC 27560
United States of America
Phone
919 328 4400
Website
Sector
Healthcare
Industry
Biotechnology
Employees
145
First IPO Date
July 26, 2018
| Name | Title | Pay | Year Born |
| Dr. Roger A. Jeffs Ph.D. | Chief Executive Officer & Director | 1.32M | 1962 |
| Mr. Russell Schundler | General Counsel & Corporate Secretary | 778,486 | 1975 |
| Mr. Michael Kaseta | Chief Operating Officer & Chief Financial Officer | 890,805 | 1976 |
| Dr. Ginger Denison | Co-Founder | 0 | N/A |
| Dr. Rajeev Saggar M.D. | Chief Medical Officer | 0 | 1974 |
| Mr. William R. Kenan Jr. | Co-Founder | 0 | N/A |
| Mr. Jason Adair | Chief Business Officer | 0 | 1972 |
| Ms. Sarah Krepp SPHR | Vice President of People & Culture | 0 | N/A |
| Mr. Scott Moomaw | Chief Commercial Officer | 0 | 1971 |
| Mr. Michael Hunter | Senior Vice President of Manufacturing Operations | 0 | N/A |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.